Evidence map›Paper›PMID 22959119›Full record

ArticleBiological psychiatry2012

Evidence for global reduction in brain cyclic adenosine monophosphate signaling in depression.

James M O'Donnell, Ying Xu

Abstract readComment
PubMed Publisher
In one paragraph

Article in Biological psychiatry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

James M O'DonnellDepartment of Behavioral Medicine and Psychiatry, School of Medicine, West Virginia University, Morgantown, West Virginia 25606, USA. jodonnell@hsc.wvu.edu
Ying Xu

Funding

NEUROPSYCHOPHARMACOLOGY OF CYCLIC AMP PDE INHIBITORSR01MH051175 · NIMH · WEST VIRGINIA UNIVERSITY · PI O'DONNELL, JAMES M · 1995 to 2007
$2.3M
CENTRALLY ACTING BETA ADRENERGIC AGONISTSR01MH040694 · NIMH · WEST VIRGINIA UNIVERSITY · PI O'DONNELL, JAMES M · 1985 to 2008
$2.1M
Phosphodiesterase-2 and Mood Disorders: Target Validation and Drug DiscoveryRC1MH088480 · NIMH · WEST VIRGINIA UNIVERSITY · PI O'DONNELL, JAMES M, ZHAN, CHANG-GUO · 2009 to 2010
$952k
Monoamine Transporter Regulation and Antidepressant ActivityR56MH040694 · NIMH · WEST VIRGINIA UNIVERSITY · PI O'DONNELL, JAMES M · 2009 to 2009
$366k
NIMH NIH HHS MH040694NIMH NIH HHS MH051175NIMH NIH HHS MH088480
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBrainCyclic Nucleotide Phosphodiesterases, Type 4Down-RegulationFemaleHumansMajor Depressive DisorderMalePhosphodiesterase 4 InhibitorsRadionuclide ImagingRolipramCyclic Nucleotide Phosphodiesterases, Type 4Phosphodiesterase 4 InhibitorsRolipram

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.